Effects of smoking cessation on serum leptin and adiponectin levels
- PMID: 26869871
- PMCID: PMC4750367
- DOI: 10.1186/s12971-015-0054-7
Effects of smoking cessation on serum leptin and adiponectin levels
Abstract
Background: Evidence on the association of leptin and adiponectin and smoking is limited and discordant. Leptin and adiponectin represent the most abundant adipokines in human plasma that play crucial roles in the pathophysiology of metabolic syndrome, atherosclerosis and insulin resistance. Leptin up-regulates the expression of several pro-inflammatory cytokines and is increased upon weight gain. Adiponectin has been shown to possess insulin sensitizing, anti -inflammatory and anti-atherogenic properties and is increased upon weight reduction. Our aim was to assess the effects of smoking cessation on serum leptin and adiponectin levels.
Methods: We assessed the changes in serum leptin and adiponectin levels, serum CRP levels and BMI in apparently healthy smokers after 3 and 6 months of abstinence from smoking. Successful cessation was confirmed by an exhaled carbon monoxide measurement. 26 healthy non-smokers were recruited as controls.
Results: Among the sample group, 32 subjects had quitted smoking at 3 months and 29 subjects at 6 months. Samples' leptin increased significantly from baseline to three months (mean change 3.76 ng/ml [95 % CI 0.89, 6.64], p =0.012) and then decreased significantly from three to six months of smoking cessation (mean change -4,29 ng/ml [95 % CI -7.34, -6.64], p = 0.008). Samples' adiponectin increased significantly from baseline to three months of abstinence from smoking (mean change 2.34 [95 % CI -0.05, 4.73], p -0.05). BMI was significantly increased (mean change 2.03 kg/m(2) [95 % CI 1.60, 2.46], p <0.05), while CRP decreased significantly from baseline to 6 months of smoking cessation (mean change -0.68 mg/dl [95 % CI -1.06, -0.30], p = 0.001).
Conclusions: Smoking quitters' leptin levels appear to increase 3 months after smoking cessation and then decrease from 3 to 6 months of abstinence from smoking. Adiponectin levels increase during the first trimester of smoking cessation. The decrease in CRP levels indicates that the low grade inflammation observed in smokers is gradually restored. The alterations of serum leptin and adiponectin after 6 months of smoking cessation suggest the same but do not reach statistically significant levels. Weight gain and changes in fat distribution may attenuate the beneficial effects of smoking cessation.
Keywords: Adiponectin; Cessation; Leptin; Smoking; Tobacco.
Figures
Similar articles
-
Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population.Atherosclerosis. 2009 Aug;205(2):632-6. doi: 10.1016/j.atherosclerosis.2009.01.022. Epub 2009 Jan 24. Atherosclerosis. 2009. PMID: 19217624
-
Alteration of inflammatory adipokines after four months of smoking abstinence in multidisciplinary intervention program.Nutr Hosp. 2018 Feb 27;35(2):434-441. doi: 10.20960/nh.1548. Nutr Hosp. 2018. PMID: 29756980 English.
-
Changes of plasma adiponectin levels after smoking cessation.Psychiatry Investig. 2014 Apr;11(2):173-8. doi: 10.4306/pi.2014.11.2.173. Epub 2014 Apr 11. Psychiatry Investig. 2014. PMID: 24843373 Free PMC article.
-
Early effects of smoking cessation and weight gain on plasma adiponectin levels and insulin resistance.Intern Med. 2011;50(7):707-12. doi: 10.2169/internalmedicine.50.4600. Epub 2011 Apr 1. Intern Med. 2011. PMID: 21467702
-
Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.Vojnosanit Pregl. 2013 Mar;70(3):284-91. doi: 10.2298/vsp1303284v. Vojnosanit Pregl. 2013. PMID: 23607240
Cited by
-
Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus.Biomedicines. 2024 Aug 17;12(8):1882. doi: 10.3390/biomedicines12081882. Biomedicines. 2024. PMID: 39200346 Free PMC article.
-
Association of anthropometric indices with continuous metabolic syndrome in children and adolescents: the CASPIAN-V study.Eat Weight Disord. 2018 Oct;23(5):597-604. doi: 10.1007/s40519-017-0455-0. Epub 2017 Nov 1. Eat Weight Disord. 2018. PMID: 29094277
-
Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation.PLoS One. 2018 Aug 7;13(8):e0201244. doi: 10.1371/journal.pone.0201244. eCollection 2018. PLoS One. 2018. PMID: 30086171 Free PMC article.
-
Adiponectin circulating levels and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA Study.Endocrine. 2017 Dec;58(3):542-552. doi: 10.1007/s12020-017-1434-y. Epub 2017 Oct 16. Endocrine. 2017. PMID: 29039145
-
Longitudinal Analysis of Diabetes Mellitus Risk: Smoking Status and Smoking Cessation.J Clin Med. 2024 Jul 4;13(13):3927. doi: 10.3390/jcm13133927. J Clin Med. 2024. PMID: 38999492 Free PMC article.
References
-
- Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis. 2005;181(2):381–8. - PubMed
-
- Miyatake N, Wada J, Kawasaki Y, Nishii K, Makino H, Numata T. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med. 2006;45(18):1039–43. - PubMed
-
- Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339(8802):1128–30. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous